Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
- 1 September 2011
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 122 (3), 567-572
- https://doi.org/10.1016/j.ygyno.2011.05.028
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Circulating Tumor Cells as a Window on Metastasis Biology in Lung CancerThe American Journal of Pathology, 2011
- Circulating tumor cells: approaches to isolation and characterizationThe Journal of cell biology, 2011
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different SchedulesJournal of Clinical Oncology, 2009
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataThe Lancet Oncology, 2009
- Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancerGynecologic Oncology, 2009
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platformGynecologic Oncology, 2009
- Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast CancerClinical Cancer Research, 2006
- Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958